Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.57
-0.24 (-3.07%)
At close: Aug 15, 2025, 2:53 PM

Indaptus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.02M -15.42M -14.32M -7.71M
Depreciation & Amortization
735.00 1.28K 1.78K 1.4K
Stock-Based Compensation
2.31M 2.97M 2.96M 1.51M
Other Working Capital
-81.8K 162.45K -425.59K -854.15K
Other Non-Cash Items
n/a -430.99K -134.16K 5.75M
Deferred Income Tax
n/a n/a n/a -5.75M
Change in Working Capital
392.25K -518.07K -1.58M -5.09M
Operating Cash Flow
-12.32M -13.41M -13.08M -11.29M
Capital Expenditures
n/a n/a -172.56K -3.85K
Cash Acquisitions
n/a n/a 172.56K 451.6K
Purchase of Investments
n/a -6.86M -29.6M n/a
Sales Maturities Of Investments
n/a 24M 13M n/a
Other Investing Acitivies
n/a n/a 172.56K n/a
Investing Cash Flow
n/a 17.14M -16.43M 447.75K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-762.7K n/a n/a 43.34M
Financial Cash Flow
4.75M n/a n/a 48.34M
Net Cash Flow
-7.58M 3.74M -29.51M 37.49M
Free Cash Flow
-12.32M -13.41M -13.25M -11.29M